Page last updated: 2024-11-02

phenylmethylsulfonyl fluoride and Hemoglobinuria, Paroxysmal

phenylmethylsulfonyl fluoride has been researched along with Hemoglobinuria, Paroxysmal in 1 studies

Phenylmethylsulfonyl Fluoride: An enzyme inhibitor that inactivates IRC-50 arvin, subtilisin, and the fatty acid synthetase complex.
phenylmethanesulfonyl fluoride : An acyl fluoride with phenylmethanesulfonyl as the acyl group.

Hemoglobinuria, Paroxysmal: A condition characterized by the recurrence of HEMOGLOBINURIA caused by intravascular HEMOLYSIS. In cases occurring upon cold exposure (paroxysmal cold hemoglobinuria), usually after infections, there is a circulating antibody which is also a cold hemolysin. In cases occurring during or after sleep (paroxysmal nocturnal hemoglobinuria), the clonal hematopoietic stem cells exhibit a global deficiency of cell membrane proteins.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zimmerman, TS1
Kolb, WP1

Other Studies

1 other study available for phenylmethylsulfonyl fluoride and Hemoglobinuria, Paroxysmal

ArticleYear
Human platelet-initiated formation and uptake of the C5-9 complex of human complement.
    The Journal of clinical investigation, 1976, Volume: 57, Issue:1

    Topics: Aminocaproates; Animals; Binding Sites, Antibody; Blood Platelets; Complement C5; Complement C6; Com

1976